Related references
Note: Only part of the references are listed.Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia
Antonio J. Amor et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Dyslipidemia in Type 1 Diabetes: A Masked Danger
Bruno Verges
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung et al.
DIABETES CARE (2020)
Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles
Antonio J. Amor et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Cardiovascular Risk in Type 1 Diabetes Mellitus
Jonathan Schofield et al.
DIABETES THERAPY (2019)
Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study
Gemma Llaurado et al.
JOURNAL OF CLINICAL MEDICINE (2019)
LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study
G. Pichler et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
The relationship of blood glucose with cardiovascular disease ismediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study
Ionut Bebu et al.
DIABETOLOGIA (2017)
Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes
Mohamed Teleb et al.
CURRENT CARDIOLOGY REPORTS (2016)
Phospholipid transfer protein activity and incident type 2 diabetes mellitus
Ali Abbasi et al.
CLINICA CHIMICA ACTA (2015)
Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy
Roger Mallol et al.
JOURNAL OF LIPID RESEARCH (2015)
Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy
Laura Brugnara et al.
PLOS ONE (2015)
Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy
Roger Mallol et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Type 2 diabetes mellitus interacts with obesity and common variations in PLTP to affect plasma phospholipid transfer protein activity
R. P. F. Dullaart et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects
Rindert de Vries et al.
ATHEROSCLEROSIS (2011)
The Role of Triglycerides in Atherosclerosis
Beatriz G. Talayero et al.
Current Cardiology Reports (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Kausik K. Ray et al.
LANCET (2009)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B - Containing lipoproteins in subjects with and without type 1 diabetes
HM Colhoun et al.
DIABETES (2002)
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes
HM Colhoun et al.
DIABETES (2002)
Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification
HM Colhoun et al.
DIABETES (2001)
Share Paper
